These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 6814784

  • 1. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason JW.
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG, Williams PD, Zygmont D, Doherty JU, Josephson ME.
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM.
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL, Buxton AE, Sadowski LM, Josephson ME.
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ, Easley AR, Mann DE.
    Am J Cardiol; 1987 Jun 01; 59(15):1319-24. PubMed ID: 3109228
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New directions in antiarrhythmic drug therapy.
    Somberg JC.
    Am J Cardiol; 1984 Aug 13; 54(4):8B-17B. PubMed ID: 6147082
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolites of antiarrhythmic drugs: are they clinically important?
    Kates RE.
    Ration Drug Ther; 1986 May 13; 20(5):1-5. PubMed ID: 3097754
    [No Abstract] [Full Text] [Related]

  • 16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM, Lee JT, Woosley RL, Echt DS.
    Circulation; 1989 Nov 13; 80(5):1247-58. PubMed ID: 2805262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.